Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 3, 2005, Pages 932-936

  Chun Fai Chan, Brian ^a   Koren, Gideon ^a   Fayez, Ibrahim ^a   Kalra, Sanjog ^a   Voyer Lavigne, Sharon ^b   Boshier, Andrew ^c   Shakir, Saad ^c   Einarson, Adrienne ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Pregnancy Riskline   (United States)

^c DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

Birth defects; Depression; Pregnancy; Smoking; Spontaneous abortions

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT;

ADULT; BIRTH WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DEPRESSION; DRUG SAFETY; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DEATH; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING CESSATION; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; STILLBIRTH; THERAPEUTIC ABORTION;

EID: 14644404955     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.09.027     Document Type: Conference Paper

References (20)

1. Product monograph of Wellbutrin SR tablets June 2000 GlaxoSmithKline North York
2. Product monograph of Zyban tablets October 2000 GlaxoSmithKline North York
3. J.A. Ascher, J.O. Cole, J.N. Colin, J.P. Feighner, R.M. Ferris, and H.C. Fibiger Bupropion: a review of its mechanism of antidepressant activity J Clin Psychiatry 56 1995 395 401
4. M.G. Goldstein Bupropion sustained release and smoking cessation J Clin Psychiatry 58 1998 68 72
5. W.E. Tucker Jr. Preclinical toxicology of bupropion: an overview J Clin Psych 44 1983 60 62
6. A.D. White, and E.B. Andrews The Pregnancy Registry Program at Glaxo Wellcome Company J Clin Psychiatry 103 1999 S362 S363
7. Bupropion pregnancy registry interim report June 2003 Glaxo Wellcome, Inc
8. Health Canada. Canadian Tobacco Use Monitoring Survey (CTUMS). Wave 1 (Feb-Jun) 2002.
9. N. Edwards, and N. Sims-Jones Smoking and smoking relapse during pregnancy and postpartum: results of a qualitative study Birth 25 1998 94 100
10. S.M. Marcus, H.A. Flynn, F.C. Blow, and K.L. Barry Depressive symptoms among pregnant women screened in obstetric settings J Women's Health 12 2003 373 380
11. S.T. Orr, and C.A. Miller Maternal depressive symptoms and poor pregnancy outcome. Review of the literature and preliminary findings Epidemiol Rev 17 1995 165 171
12. R.A. Steer, T.O. Scholl, M.L. Hediger, and R.L. Fischer Self-reported depression and negative pregnancy outcomes J Clin Epidemiol 45 1992 1093 1099
13. B. Zuckerman, H. Bauchner, S. Parker, and H. Cabral Maternal depressive symptoms during pregnancy, and newborn irritability J Dev Behav Pediatr 11 1999 190 194
14. B. Zuckerman, H. Amaro, H. Bauchner, and H. Cabral Depressive symptoms during pregnancy: relationship to poor health behaviors Am J Obstet Gynecol 160 1989 1107 1111
15. A. Pastuszak, B. Schick-Boschetto, C. Zuber, M. Feldkamp, M. Pinelli, and S. Sihn Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) JAMA 269 1993 2246 2248
16. N.A. Kulin, A. Pastuszak, S.R. Sage, B. Schick-Boschetto, G. Spivey, and M. Feldkamp Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study JAMA 279 1998 609 610
17. A. Einarson, B. Fatoye, M. Sarkar, S.V. Lavigne, J. Brochu, and C. Chambers Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study Am J Psychiatry 158 2001 1728 1730
18. A. Einarson, L. Bonari, S. Voyer-Lavigne, A. Addis, D. Matsui, and Y. Johnson A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy Can J Psychiatry 48 2003 106 110
19. Hemels M. Rates of abortions following exposure to antidepressants: a meta-analysis. Thesis defended for Degree of Masters of Science, department of Pharmacology, University of Toronto: Canada; June 2003.
20. W. Katon, M. von Korff, E. Lin, T. Bush, and J. Ormel Adequacy and duration of antidepressant treatment in primary care Med Care 30 1992 67 76